logo BDSP

Base documentaire


  1. Are stimulants overprescribed ? Treatment of ADHD in four U.S. communities.

    Article - En anglais

    Objective 

    To address rising concerns about the possible overdiagnosis of attention-deficit hyperactivity disorder (ADHD) and overtreatment with stimulants.

    To date, almost no studies have examined ADHD in unbiased community-based studies, ascertaining both the prevalence of the diagnosis within nonreferred populations and the extent to which various treatments (i.e., stimulant medication, mental health treatments, and educational interventions) are used.

    Method 

    As a part of the Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study, the authors examined epidemiological survey data obtained from 1,285 children and their parents across 4 U.S. communities.

    Analyses examined the frequency of children's ADHD diagnosis, the extent to which medications were prescribed, as well as the provision of other services (e.g., psychosocial treatments, school-based educational interventions).

    Results 

    Findings indicated that 5.1% of children met full DSM-III-R ADHD criteria across the pooled sample.

    Only 12.5% of children meeting ADHD criteria had been treated with stimulants during the previous 12 months.

    Some children who had been prescribed stimulants did not meet full ADHD diagnostic criteria, but these children manifested high levels of ADHD symptoms, suggesting that the medication had been appropriately prescribed.

    Children with ADHD were generally more likely to receive mental health counseling and/or school-based interventions than medication. (...)

    Mots-clés Pascal : Trouble attention, Hyperactivité, Critère, Diagnostic, Service santé, Prescription médicale, Stimulant SNC, Psychotrope, Santé mentale, Etats Unis, Amérique du Nord, Amérique, Enfant, Homme, Adolescent

    Mots-clés Pascal anglais : Attentional disorder, Hyperactivity, Criterion, Diagnosis, Health service, Medical prescription, CNS stimulant, Psychotropic, Mental health, United States, North America, America, Child, Human, Adolescent

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0370179

    Code Inist : 002B02B02. Création : 14/12/1999.